Omnilink Elite 1012622-39Recalls & reported problems
Abbott Vascular Inc. · Omnilink Elite Vascular Balloon-Expandable Stent System 6.0 mm x 39 mm x 80 cm Over-The-Wire · Class 3 · Implant
All models of Omnilink Elite (42)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648179204), received between Dec 27, 2020 and Jun 20, 2024 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Dislodged or Dislocated2
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Advance1
- Improper or Incorrect Procedure or Method1
- Migration1
Patient problems
- Device Embedded In Tissue or Plaque1
- Embolism/Embolus1
- Foreign Body In Patient1
- No Patient Involvement1
- Obstruction/Occlusion1
- Thrombosis/Thrombus1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJun 20, 2024Difficult to Advance; Device Dislodged or Dislocated; Difficult to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WITH HEAVY CALCIFICATION. THE 6X39MM OMNILINK ELITE BALLOON EXPANDING STENT (BES) WAS BEING ADVANCED THROUGH THE TARGET LESION WITH RESISTANCE DUE TO THE ANATOMY. THE BES COULD NOT COMPLETELY CROSS THE LESION; THEREFORE, THE BES WAS REMOVED FROM THE PATIENT AND WHEN THE STENT SHAFT WAS REMOVED FROM THE SHEATH THE STENT WAS NOTED TO NOT BE ON THE BALLOON. ANGIOGRAPHY FOUND THAT THE STENT WAS IN THE RIGHT ILIAC ARTERY. THEREFORE, THE BALLOON OF THE DELIVERY SYSTEM WAS RE-ADVANCED THROUGH THE STENT STRUTS AND THE STENT WAS DEPLOYED IN THE RIGHT EXTERNAL ILIAC ARTERY. AN ARMADA BALLOON WAS THEN USED TO FURTHER DILATE THE STENT. THERE WAS NO ADVERSE PATIENT SEQUELA. ANOTHER STENT WAS IMPLANTED AT THE TARGET LESION TO COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Device Embedded In Tissue or Plaque
MAUDE report 19579683 ↗InjuryJan 3, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE RENAL ARTERY. TWO OMNILINK ELITE STENTS, 6.0X39MM AND 6.0X29MM, WERE IMPLANTED. AFTER THE PROCEDURE, A SERIES OF COMPLICATIONS AROSE IN WHICH THE ARTERIES BECAME BLOCKED AND STOPPED FLOW OF BLOOD TO THE KIDNEYS. IT APPEARS THAT PLAQUE THAT HAD LOOSENED BECAME LODGED AT THE END OF THE STENTS AND BLOOD CLOTS FORMED. THE DOCTORS WENT BACK IN TO TRY AND REMOVE THE BLOCKAGE AND AFTER MANY HOURS WERE ONLY ABLE TO CLEAR ONE OF THEM, WHILE WORKING ON CLEARING ONE ARTERY THE OTHER ARTERY STILL BLOCKED RESULTED IN KIDNEY FAILURE BECAUSE IT WENT TOO LONG WITHOUT BLOOD FLOW AND THE PATIENT LOST FUNCTION OF THAT KIDNEY. THERE WAS ADDITIONAL HOSPITALIZATION DUE TO THE RENAL FAILURE. STILL WAITING TO HEAR THE RESULTS OF HOW THE ONE KIDNEY THAT WAS ABLE TO GET BLOOD FLOW IS FUNCTIONING AND IF ANY DAMAGE HAS OCCURRED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Thrombosis/Thrombus
MAUDE report 18436575 ↗InjuryApr 8, 2022Migration; Migration
IT WAS REPORTED THAT THE PROCEDURE PERFORMED WAS TO TREAT A LESION IN DISTAL COMMON ILIAC ARTERY. THE OMNILINK ELITE STENT DELIVERY SYSTEM (SDS) WAS ADVANCED TO THE TARGET LESION WITHOUT ISSUE AND THE STENT WAS DEPLOYED AND WAS FULLY APPOSED. THE PHYSICIAN THEN PASSED A SHEATH THROUGH THE IMPLANTED STENT TO DO A COMPLETION RUN AND THE STENT MIGRATED INTO THE DISTAL AORTA. THE PHYSICIAN ATTEMPTED TO SNARE THE DISLODGED STENT FROM THE AORTA, BUT WAS UNSUCCESSFUL. A BALLOON CATHETER WAS ABLE TO CAPTURE THE STENT AND STENTED IT IN A NON-ABBOTT COVERED STENT. THE CONTRALATERAL SIDE DISSECTED LATER IN THE PROCEDURE AND THE PATIENT UNDERWENT FEMOROFEMORAL (FEMORAL-FEMORAL) BYPASS SURGERY; HOWEVER, IT WAS REPORTED THAT THIS WAS UNRELATED TO THE OMNILINK STENT. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Embolism/Embolus; Foreign Body In Patient; Obstruction/Occlusion
MAUDE report 14053171 ↗MalfunctionDec 27, 2020Improper or Incorrect Procedure or Method; Device Dislodged or Dislocated; Improper or Incorrect Procedure or Method; Device Dislodged or Dislocated
IT WAS REPORTED THE OMINILINK STENT DELIVERY SYSTEM WAS PREPPED BEFORE REMOVAL OF THE PROTECTIVE SHEATH, AND THE STENT CAME OFF THE BALLOON. THE DEVICE WAS NOT USED, AND THERE WAS NO PATIENT INVOLVEMENT. THERE WAS NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 11074128 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Absolute Pro 1012536-100Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page